About Marksans Pharma
Marksans Pharma is a company based in Mumbai (India) founded in 2001 by Mark Saldanha. The company has 1,350 employees as of March 31, 2024. Marksans Pharma has completed 2 acquisitions, including Access HealthCare and Time-Cap Labs. Marksans Pharma offers products and services including Pharmaceutical Formulations and OTC Consumer Products.
- Headquarter Mumbai, India
- Employees 1350 as on 31 Mar, 2024
- Founders Mark Saldanha
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Marksans Pharma Limited
-
Annual Revenue
$306.32 M (USD)20.26as on Mar 31, 2025
-
Net Profit
$44.6 M (USD)21.32as on Mar 31, 2025
-
EBITDA
$62.04 M (USD)15.09as on Mar 31, 2025
-
Latest Funding Round
$45.78 M (USD), Post-IPO
Jan 20, 2023
- Investors
-
Employee Count
1350
as on Mar 31, 2024
-
Investments & Acquisitions
Access HealthCare
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Marksans Pharma
Marksans Pharma is a publicly listed company on the NSE with ticker symbol MARKSANS in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Marksans Pharma
Marksans Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Formulations and OTC Consumer Products.
Finished dosage formulations are produced for various therapeutic segments, including cardiovascular and oncology, with a focus on global distribution
Over-the-counter products are offered for pain management and digestive health, catering to consumer needs in multiple markets
Funding Insights of Marksans Pharma
Investors in Marksans Pharma
Marksans Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Orbimed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked |
Investor details for Marksans Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Marksans Pharma
Marksans Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Access HealthCare and Time-Cap Labs.
Investment portfolio details for Marksans Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Skin care pharmaceutical products are manufactured by Access HealthCare.
|
Locked | Locked | 2019 | Locked | |
|
Pharma company with expertise in tablet coating and specializing in delayed and sustained release dosages
|
Locked | Locked | 1979 | Locked |
Complete acquisition details for Marksans Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Marksans Pharma
Detailed financials for Marksans Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Marksans Pharma Comparisons
Peer comparison for Marksans Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Marksans Pharma
Detailed competitors of Marksans Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Marksans Pharma
Complete news archive for Marksans Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Marksans Pharma
Marksans Pharma was founded in 2001 and raised its 1st funding round 14 years after it was founded.
Marksans Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Mark Saldanha is the current CEO of Marksans Pharma. They have also founded this company.
As of Mar 31, 2024, the latest employee count at Marksans Pharma is 1,350.
Annual revenue of Marksans Pharma is $306.32M as on Mar 31, 2025.
Marksans Pharma was founded in 2001 and is headquartered in Mumbai, India. Operations focus on the pharmaceutical sector, where drug formulation manufacturing, development, and marketing of finished dosage products are conducted. A range of products including blow fill-seal ampoules, liquid and powder stick-packs, tablets, bottles, suppositories, and pessaries is offered to support diverse pharmaceutical needs.
Marksans Pharma offers Pharmaceutical Formulations and OTC Consumer Products.
Yes, Marksans Pharma is publicly traded on NSE under the ticker symbol MARKSANS.
Marksans Pharma has made 2 acquisitions, including Access HealthCare, and Time-Cap Labs.
Marksans Pharma has 1 investor. Key investors include Orbimed.
The ticker symbol of Marksans Pharma is MARKSANS on NSE.